Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02IAR
|
|||
| Former ID |
DIB006739
|
|||
| Drug Name |
Nov-038
|
|||
| Synonyms |
Nov-051; CD40 antisense oligonucleotides (Smarticles), Novosom; CD40 antisense oligonucleotides (charge-reversible liposome delivery), Novosom; CD40 mRNA-targeting antisense oligonucleotides (inflammation/B-cell malignancies); CD40 mRNA-targeting antisense oligonucleotides (inflammation/B-cell malignancies), Isis Pharmaceuticals; CD40 mRNA-targeting antisense oligonucleotides (inflammation/B-cell malignancies), Novosom
Click to Show/Hide
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.